Trial Profile
A major data real world study of apatinib in the treatment of gastric cancer
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 14 Aug 2018
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary)
- Indications Adenocarcinoma; Gastric cancer
- Focus Adverse reactions
- 14 Aug 2018 New trial record